< Back to companies
Ablacon

Ablacon

Wheat Ridge, Colorado, United States

Ablacon, Inc. is a Wheat Ridge, CO-­­based company with offices in Munich, Germany and Menlo Park, CA, developing an advanced mapping system to guide the treatment of atrial fibrillation, the most frequent cardiac arrythmia. The company's system uses advanced algorithms and machine learning to precisely localize and characterize the sources of AF and to guide targeted therapy by visualizing the Electrographic Flow within the cardiac chambers. The company's technology obtained CE Mark in 2018 and is currently being used in Europe.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2015
Website
www.cortexep.com/

Categories

Cardiovascular Disease
Only accessible to MedStartr community members. Join now

What do you think of Ablacon?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now